Waiting
Login processing...

Trial ends in Request Full Access Tell Your Colleague About Jove
Journal / Cancer Research / Gepooltes shRNA-Bibliotheksscreening zur…
JoVE Journal
Cancer Research
Author Produced

A subscription to JoVE is required to view this content.

JoVE Journal Cancer Research
Gepooltes shRNA-Bibliotheksscreening zur Identifizierung von Faktoren, die einen Phänotyp der Arzneimittelresistenz modulieren
Processing the Single-Cell Shear Assay Imaging Data (Video) | JoVE
Journal (Cancer Research)
Processing the Single-Cell Shear Assay Imaging Data (Video) | JoVE
Culture of Bladder Cancer Organoids as Precision Medicine Tools
Journal (Cancer Research)
Culture of Bladder Cancer Organoids as Precision Medicine Tools
 
Click here for the English version

Gepooltes shRNA-Bibliotheksscreening zur Identifizierung von Faktoren, die einen Phänotyp der Arzneimittelresistenz modulieren

Article DOI: 10.3791/63383-v • 14:51 min • June 17th, 2022
June 17th, 2022 •
1,2, 1,2, 2,3, 2,3, 1,2,3, 1,2,3
1Department of Clinical Haematology, Christian Medical College, 2Department of Biotechnology, Thiruvalluvar University, 3Centre for Stem Cell Research, Christian Medical College

Chapters

Summary
Automatic Translation

Please note that all translations are automatically generated.

Click here for the English version.

Das RNAi-Screening (High-Throughput-RNA-Interferenz) unter Verwendung eines Pools lentiviraler shRNAs kann ein Werkzeug sein, um therapeutisch relevante synthetische tödliche Ziele in Malignomen nachzuweisen. Wir bieten einen gepoolten shRNA-Screening-Ansatz zur Untersuchung der epigenetischen Effektoren bei akuter myeloischer Leukämie (AML).

Tags

Krebsforschung Ausgabe 184 Hochdurchsatz-Screening RNAi-Screening shRNA epigenetischer Faktor Cytarabin AraC-Resistenz
Read Article

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
Simple Hit Counter